Million Insights
Market Research Released A New Research Report On Global Next Generation Cancer
Diagnostics Market - Forecast Up To 2025. Report Provide Overview Of Top Key
Players, Share Analysis, Size, Stake, Progress, Trends And Their Strategic
Profiling In The Market, Comprehensively Analyzing Their Core Competencies, And
Drawing A Competitive Landscape For The Market.
Pune, India - Next Generation Cancer Diagnostics Market
size was worth USD 4,964.05 million in 2016 which is anticipated to grow at a
CAGR of more than 9.7% over the forecast period. Rise in mortality rate due to
the increasing occurrence of the cancer, second most predominant disease
accounting for approximately 8.8 million deaths in 2015 is anticipated to
escalate the market for these tests.
Advancements in tests enable early diagnosis and assist
efficient detection of different types of tumors which in turn is expected to
promote growth over the projected period. The introduction of new products by
large bodies, merger, and acquisitions, and joint agreements such as the
development of RNA-Seq Kit version by Agilent Technologies Inc. and Agendia
Inc. are the factors accountable for the estimated CAGR.
To Get Sample Report
visit @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market/request-sample
Incorporation of technological advancements such as melting
curve examination for identification of mutations, qPCR tools for profiling of
tumor in clinical test centers, and gene deletions are accountable for the
largest share apprehended by multiplexing and qPCR segment.
With the development of next-generation sequencing
technology, the use of traditional methods such as protein and DNA microarrays
is expected to decrease through the years. Other factors such as data
interpretation tools, growth of supportive library preparation procedures, and
technological advancements are accountable for the lucrative adoption of next
generation oncology tests among researchers.
Cancer Type Insights
Major categorization for the types of cancer includes
cervical, breast, lung, colorectal, and other tumor forms. The other types
constitute leukemia, prostate, bladder, brain, skin, uterine, esophageal,
Non-Hodgkin lymphoma, ovarian, liver, and thyroid.
In 2015, as per World Health Organization lung cancer was
accountable for approximately 1.7 million deaths. Moreover, breast cancer
incidence is also estimated to grow thereby escalating the demand for screening
and diagnostic technologies.
Application Insights
Growth in the number of research schemes to develop novel
products and services which enable primary detection of tumor-causing mutations
is expected to affect the advancement in genetic analysis over the forecast period.
Biomarker tests offer greater sensitivity in screening and also demonstrate 90%
accuracy levels in investigational studies which is attributive to induce
progress in the coming years.
To Browse Complete
Report visit @ https://www.millioninsights.com/industry-reports/next-generation-cancer-diagnostics-market
Market Segment:
Technology Outlook (Revenue, USD Million, 2013 - 2024)
• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse
Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays
Application Outlook (Revenue, USD Million, 2013 - 2024)
• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis
Get in touch
At Million Insights, we work
with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist,
USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor,
Manikchand Galleria,
Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
tel: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com
No comments:
Post a Comment